Ginny L. Bumgardner

4.7k total citations · 1 hit paper
136 papers, 3.7k citations indexed

About

Ginny L. Bumgardner is a scholar working on Surgery, Transplantation and Immunology. According to data from OpenAlex, Ginny L. Bumgardner has authored 136 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Surgery, 63 papers in Transplantation and 41 papers in Immunology. Recurrent topics in Ginny L. Bumgardner's work include Renal Transplantation Outcomes and Treatments (63 papers), Organ Transplantation Techniques and Outcomes (49 papers) and Immune Cell Function and Interaction (28 papers). Ginny L. Bumgardner is often cited by papers focused on Renal Transplantation Outcomes and Treatments (63 papers), Organ Transplantation Techniques and Outcomes (49 papers) and Immune Cell Function and Interaction (28 papers). Ginny L. Bumgardner collaborates with scholars based in United States, Canada and United Kingdom. Ginny L. Bumgardner's co-authors include Elmahdi Elkhammas, Ronald M. Ferguson, Mitchell L. Henry, Elizabeth Davies, Charles G. Orosz, Ronald P. Pelletier, Michael E. Falkenhain, Fernando G. Cosio, Mark D. Pescovitz and Robert S. Gaston and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Ginny L. Bumgardner

134 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

1998 667 citations Ginny L. Bumgardner, Mark D. Pescovitz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ginny L. Bumgardner United States	32	1.9k	1.7k	806	679	641	136	3.7k
Joshua Miller United States	39	2.7k 1.4×	2.0k 1.2×	929 1.2×	508 0.7×	649 1.0×	131	4.7k
Guido G. Persijn Netherlands	35	2.1k 1.1×	2.1k 1.3×	782 1.0×	1.2k 1.8×	350 0.5×	114	4.0k
Diego Cantarovich France	29	2.0k 1.1×	1.4k 0.8×	616 0.8×	526 0.8×	179 0.3×	148	3.6k
Stéphan Busque United States	27	1.4k 0.7×	1.1k 0.6×	499 0.6×	667 1.0×	281 0.4×	69	2.6k
Patrick G. Dean United States	32	2.6k 1.4×	1.9k 1.1×	683 0.8×	805 1.2×	156 0.2×	105	4.1k
Bernd Döhler Germany	37	3.4k 1.8×	2.2k 1.3×	749 0.9×	886 1.3×	374 0.6×	103	5.2k
J.M. Gloor United States	25	3.3k 1.7×	1.7k 1.0×	1.0k 1.3×	622 0.9×	182 0.3×	33	4.0k
David W. Gjertson United States	29	2.2k 1.2×	2.1k 1.3×	325 0.4×	1.6k 2.4×	305 0.5×	69	3.9k
Josefina Alberú Mexico	23	1.6k 0.8×	1.0k 0.6×	407 0.5×	782 1.2×	131 0.2×	140	3.0k
Oriol Bestard Spain	32	2.1k 1.1×	1.2k 0.7×	907 1.1×	413 0.6×	143 0.2×	159	3.6k

Countries citing papers authored by Ginny L. Bumgardner

Since Specialization

Citations

This map shows the geographic impact of Ginny L. Bumgardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginny L. Bumgardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginny L. Bumgardner more than expected).

Fields of papers citing papers by Ginny L. Bumgardner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ginny L. Bumgardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginny L. Bumgardner. The network helps show where Ginny L. Bumgardner may publish in the future.

Co-authorship network of co-authors of Ginny L. Bumgardner

This figure shows the co-authorship network connecting the top 25 collaborators of Ginny L. Bumgardner. A scholar is included among the top collaborators of Ginny L. Bumgardner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginny L. Bumgardner. Ginny L. Bumgardner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zimmerer, Jason M., Qiang Zeng, Anjali A. Satoskar, et al.. (2024). Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells. The Journal of Immunology. 212(9). 1504–1518. 3 indexed citations

Zimmerer, Jason M., Jing Han, Qiang Zeng, et al.. (2022). Antibody-suppressor CXCR5+CD8+ T cellular therapy ameliorates antibody-mediated rejection following kidney transplant in CCR5 KO mice. American Journal of Transplantation. 22(6). 1550–1563. 9 indexed citations

Singh, Navdeep, Austin Schenk, Ginny L. Bumgardner, et al.. (2021). Machine perfusion of kidney allografts affects early but not late graft function. The American Journal of Surgery. 223(4). 804–811. 9 indexed citations

Zimmerer, Jason M., et al.. (2021). CXCR5+CD8+ T Cells: A Review of Their Antibody Regulatory Functions and Clinical Correlations. The Journal of Immunology. 206(12). 2775–2783. 16 indexed citations

Nguyen, Michelle, Guy Brock, Jason Benedict, et al.. (2020). “Early” and “Late” Hospital readmissions in the first year after kidney transplant at a single center. Clinical Transplantation. 34(3). e13822–e13822. 7 indexed citations

Zimmerer, Jason M., Thomas Pham, Virginia M. Sanders, & Ginny L. Bumgardner. (2010). CD8+ T Cells Negatively Regulate IL-4–Dependent, IgG1-Dominant Posttransplant Alloantibody Production. The Journal of Immunology. 185(12). 7285–7292. 21 indexed citations

Horne, Phillip H., Jason M. Zimmerer, Keri E. Lunsford, et al.. (2008). Critical Role of Effector Macrophages in Mediating CD4-Dependent Alloimmune Injury of Transplanted Liver Parenchymal Cells. The Journal of Immunology. 181(2). 1224–1231. 20 indexed citations

Lunsford, Keri E., et al.. (2005). Targeting LFA-1 and CD154 Suppresses the In Vivo Activation and Development of Cytolytic (CD4-Independent) CD8+ T Cells. The Journal of Immunology. 175(12). 7855–7866. 30 indexed citations

Vitellas, Kenneth M., Amer Rajab, Ronald P. Pelletier, et al.. (2004). Magnetic Resonance Cholangiography With Mangafodipir Trisodium (Teslascan) to Evaluate Bile Duct Leaks After T-Tube Removal in Liver Transplantation. Journal of Computer Assisted Tomography. 28(5). 613–616. 7 indexed citations

10.

Go, Michael R. & Ginny L. Bumgardner. (2002). OKT3 (muromonab-CD3) associated hepatitis in a kidney transplant recipient. Transplantation. 73(12). 1957–1959. 4 indexed citations

11.

Bumgardner, Ginny L., Ian R. Hardie, Robert W. Johnson, et al.. (2001). RESULTS OF 3-YEAR PHASE III CLINICAL TRIALS WITH DACLIZUMAB PROPHYLAXIS FOR PREVENTION OF ACUTE REJECTION AFTER RENAL TRANSPLANTATION1. Transplantation. 72(5). 839–845. 88 indexed citations

12.

Bumgardner, Ginny L., Eleanor L. Ramos, Amy Lin, & Flavio Vincenti. (2001). DACLIZUMAB (HUMANIZED ANTI-IL2R?? MAB) PROPHYLAXIS FOR PREVENTION OF ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS WITH DELAYED GRAFT FUNCTION1,2. Transplantation. 72(4). 642–647. 20 indexed citations

13.

Gao, Donghong, Jiashun Li, Charles G. Orosz, & Ginny L. Bumgardner. (2000). Different Costimulation Signals Used by Cd4+ and Cd8+ Cells That Independently Initiate Rejection of Allogenic Hepatocytes in Mice. Hepatology. 32(5). 1018–1028. 38 indexed citations

14.

Cosío, Borja G., Ronald P. Pelletier, Daniel D. Sedmak, et al.. (1999). PATHOLOGIC CLASSIFICATION OF CHRONIC ALLOGRAFT NEPHROPATHY: PATHOGENIC AND PROGNOSTIC IMPLICATIONS1. Transplantation. 67(5). 690–696. 28 indexed citations

15.

Pelletier, Ronald P., Fernando G. Cosio, Mitchell L. Henry, et al.. (1998). Acute rejection following renal transplantation. Evidence that severity is the best predictor of subsequent graft survival time. Clinical Transplantation. 12(6). 543–552. 22 indexed citations

16.

Henry, Mitchell L., Elmahdi Elkhammas, Ginny L. Bumgardner, Ronald P. Pelletier, & R M Ferguson. (1998). Outcome of 300 Consecutive Pancreas–Kidney Transplants. Transplantation Proceedings. 30(2). 291–291. 9 indexed citations

17.

Cosio, Fernando G., Elmahdi Elkhammas, Mitchell L. Henry, et al.. (1998). FUNCTION AND SURVIVAL OF RENAL ALLOGRAFTS FROM THE SAME DONOR TRANSPLANTED INTO KIDNEY-ONLY OR KIDNEY-PANCREAS RECIPIENTS1. Transplantation. 65(1). 93–99. 6 indexed citations

18.

Cosio, Fernando G., John Dillon, Michael E. Falkenhain, et al.. (1995). Racial differences in renal allograft survival: The role of systemic hypertension. Kidney International. 47(4). 1136–1141. 113 indexed citations

19.

Almond, P. Stephen, Ginny L. Bumgardner, Sally Chen, & Arthur J. Matas. (1992). Pretransplant sensitization with major histocompatibility complex class I+ class II− hepatocytes leads to accelerated skin graft rejection. Journal of Surgical Research. 53(2). 182–187. 1 indexed citations

20.

Bumgardner, Ginny L. & Richard L. Simmons. (1988). Newer cephalosporins: Lessons to be learned from clinical trials in intraabdominal infections. The American Journal of Surgery. 155(5). 5–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact